Antibody Invest Information

Companies
Merck Acquires Curon's Bispecific Antibody for $1.3 Billion Aug 13, 2024
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin Nov 9, 2023